written on 06.03.2014

Novartis may face tough action over 'fake' documents in India


The case, in which the Swiss company is reported to have tendered an "unconditional apology", may also see a broader follow-up investigation by the Indian regulator to verify documentation for a clutch of its other imported products or even site…